Tuesday, July 23, 2019
wellness India Expo
Home Tags Novartis

Tag: Novartis

Alcon debuts as independent, publicly traded company

After the company completed its separation from Novartis, it has begun trading on SIX Swiss Exchange and New York Stock Exchange...............

Aurobindo Pharma acquires Sandoz’s dermatology, oral solid business in US for...

Agreement comprises the Sandoz US generic oral solids and Sandoz US dermatology businesses with approximately 300 products and H1 2018 sales of USD 0.6 billion. Transaction supports the Sandoz strategy of focusing on complex generics, value-added medicines and biosimilars...……..

Post NHS approval, sky is the limit for Novartis’ CAR-T therapy:...

According to GlobalData forecasts, the Novartis CAR-T therapy, Kymriah is expected to hit over $1billion sales revenue by 2023 in the US alone......……….

Pricing adjustments for CAR-T therapies likely to take place in 2018,...

A fairly comprehensive study reported in February 2018 on the Health Affairs Blog claims that Novartis could lower the price of Kymriah by two-thirds and still achieve a profit..................

Digital health can prove cost effective for drug development, says GlobalData

As per the leading data and analytics firm, GlobalData, the research and development in the pharmaceutical and drug companies could get a major boost due to use of artificial intelligence and other digital technologies................

Novartis’ Scapho shows pioneering 4-year data in preventing Ankylosing Spondylitis progression

For the first time for any biologic, data show almost 80 percent of ankylosing spondylitis (AS) patients on Scapho have no radiographic progression of the spine at 4 years.......

“Universal Health Coverage in India can’t succeed with one-size-fits-all approach”

Mentioned Mr Harald Nusser, Head of Novartis-Social Business who believes that India requires its own homegrown model of health coverage system as the ones already in place in western nations won’t necessarily work here..........

Novartis & MMV launch patient trial to test KAF156 against MDR-malaria...

The KAF156 has potential to be a game-changer in malaria elimination, rapidly clearing malaria infection, including resistant strains, and blocking parasite transmission......

BioVoice eMag June 2017 Issue-1 Volume-2

BioVoice eMag June 2017 Issue-1 Volume-2: The 1st anniversary edition of BioVoice includes the cover story, ‘The Milestones’ that looks at the various top trends,...

BioVoice eMag March 2017 Issue-10 Volume-1

BioVoice eMag March 2017 Issue-10 Volume-1: This edition of BioVoice in its detailed cover story highlights the gains and pains of the budget 2017. The...